Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001260391 | SCV001437354 | likely benign | not specified | 2020-09-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001532117 | SCV001747527 | uncertain significance | not provided | 2021-08-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001705705 | SCV001822126 | likely benign | Cystic fibrosis | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001705705 | SCV002747464 | likely benign | Cystic fibrosis | 2019-10-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |